What Is Itamar Medical Company Famous for?

Itamar medical is a company which is focusing on the integration of the management of sleep apnea into the cardiac patient care pathway. The core strategies of this medical technology company include the development, manufacture, and sales of the WatchPat product line of diagnosis based on the proprietary PAT signal which has been proven as a simple, reliable, scalable and a comprehensive alternative to airflow because it enables point of deployment versatility. They are also manufacturers of the total sleep solution which is a product that includes an organization of field support, partnerships along with the core and supporting technologies which can enable all physicians in general and particularly cardiologists to provide a seamless and complete continuum of care for sleep apnea patients as part of their care pathway.

This medical technology company has also developed and is presently marketing the EndoPAT system which is an endothelial function assessment tool for the classification of risks and is used by clinicians, researchers as well as pharmaceutical companies easily and reliably to quantify and track arterial health.

Itamar medical is working in collaboration with some leading sleep physicians and industry partners and has pioneered a novel cross-disciplinary model of care developed for the combination of sleep apnea management into cardiac patients care pathway. The total sleep solutions can expand the reach of sleep services by providing point-of-care variability, a scalable model for the management of large numbers of patients while reducing waiting times along with overall costs to provide optimized IT systems. It also provides human field resources to support the large numbers of the undiagnosed pool of cardiac patients that are suffering from the comorbidity of sleep apnea. The total sleep solutions can simplify the access of the patient for the care of sleep apnea. It can also improve patient flow management while optimizing therapy and patient compliance.

The WatchPat device which is cleared by the FDA for the diagnosis of sleep breathing disorders is also developed by Itamar medical. The WatchPat device is a tiny wrist-mounted device which allows for testing in the comfort of the patients own home.

Itamar medical has signed numerous strategic marketing agreements for its products over the past several years. The agreements include companies such as Medtronic and DeVilbiss in the US, Nihon Kohden in Japan along with Phillips Respironics.

The proprietary PAT technology developed by Itamar medical can allow noninvasive recording, analysis, and measurement of peripheral arterial tonometry. The PAT signal identifies changes in the patient’s pulsatile arterial volume to provide a window to the cardiovascular system along with the sympathetic bunch of autonomic nervous system.

Itamar medical has the vision to become a world leader in providing complete sleep solutions to cardiac patients. In order to improve cardiac patient care with the combination of innovative and clinically efficient sleep apnea management solutions, the medical technology company has introduced solutions to provide continuing care which can also reduce the overall cost of healthcare.

The corporate headquarters, research and development facilities, and the manufacturing for Itamar medical are located in Israel. Itamar medical markets it’s services and supports its products throughout the world. It also has wholly-owned subsidiaries in the US and Japan along with distribution channels across the globe.

Numerous cardiac patients are unaware they could possibly be suffering from sleep apnea and when informed to undergo testing they generally make an attempt to defer the decision because of the high costs involved along with the difficulties the procedure involves. Waiting for appointments to undergo sleep testing is the problem apart from the long distances they need to travel in order to reach a certified sleep clinic. This results in the delay in cardiac care leading to numerous fatalities in the US. The products developed by Itamar medical have perhaps put an end to this problem because patients are realizing they can conveniently undergo testing for sleep apnea from the comfort of their home at a reduced cost and begin their treatments without any delays.